| Literature DB >> 36249809 |
Anna K Laskowska1,2, Aleksandra Wilczak3, Weronika Skowrońska4, Piotr Michel5, Matthias F Melzig6, Monika E Czerwińska2,7.
Abstract
Preparations from Hippophaë rhamnoides L. (sea buckthorn) have been traditionally used in the treatment of skin and digestive disorders, such as gastritis, gastric and duodenal ulcers, uterine erosions, as well as oral, rectal, and vaginal mucositis, in particular in the Himalayan and Eurasian regions. An influence of an aqueous extract from the fruits of H. rhamnoides (HR) on leakage of lipopolysaccharide (LPS) from Escherichia coli through gut epithelium developed from the human colorectal adenocarcinoma (Caco-2) monolayer in vitro and glucose transporter 2 (GLUT2) translocation were the principal objectives of the study. Additionally, the effect of HR on the production of pro- and anti-inflammatory cytokines (interleukins: IL-8, IL-1β, IL-10, IL-6; tumor necrosis factor: TNF-α) by the Caco-2 cell line, human neutrophils (PMN), and peripheral blood mononuclear cells (PBMC) was evaluated. The concentration of LPS on the apical and basolateral sides of the Caco-2 monolayer was evaluated with a Limulus Amebocyte Lysate (LAL) assay. GLUT2 translocation was evaluated using an immunostaining assay, whereas secretion of cytokines by cell cultures was established with an enzyme-linked immunosorbent (ELISA) assay. HR (500 μg/ml) significantly inhibited LPS leakage through epithelial monolayer in vitro in comparison with non-treated control. The treatment of Caco-2 cells with HR (50-100 μg/ml) showed GLUT2 expression similar to the non-treated control. HR decreased the secretion of most pro-inflammatory cytokines in all tested models. HR might prevent low-grade chronic inflammation caused by metabolic endotoxemia through the prevention of the absorption of LPS and decrease of chemotactic factors released by immune and epithelial cells, which support its use in metabolic disorders in traditional medicine.Entities:
Keywords: epithelium; gut barrier leakage; low-grade inflammation; metabolic endotoxemia; sea buckthorn
Year: 2022 PMID: 36249809 PMCID: PMC9561609 DOI: 10.3389/fphar.2022.981874
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1Concentration of LPS [EU/mg protein] in the apical and basolateral side of Caco-2 monolayer after the HR application. HR—aqueous extract from the fruit of Hipopphaë rhamnoides. # p < 0.001 vs. (-)LPS (A, apical side); *p <0.05 vs. (+)LPS (B, basolateral side).
FIGURE 2Effect of HR on IL-8 secretion by Caco-2 (pg/mg protein ± SEM) in the apical (A) and basolateral (B) side of Caco-2 monolayer after the HR application. HR—aqueous extract from the fruit of Hipopphaë rhamnoides; Dex—dexamethasone; st.—mixture of IL-1β/TNF-α/IFN-γ/LPS. # p < 0.001 vs. (−) st.; * p < 0.05, ** p < 0.001 vs. (+) st.
FIGURE 3Effect of HR on secretion of cytokines (mean ± SEM [%]) by PMN (A–C) and PBMC (D–F). HR—aqueous extract from the fruit of Hipopphaë rhamnoides; Dex—dexamethasone. # p <0.001 vs. (−) LPS; *p <0.05, **p <0.001 vs. (+) LPS.
FIGURE 4Effect of HR on cells viability (A) Caco-2 cells; (B) PMN; (C) PBMC. Data are expressed mean ± SEM [%]. Control—non-treated control cells; HR—aqueous extract from the fruit of Hipopphaë rhamnoides; Dex—dexamethasone. * p <0.001 vs. control.
FIGURE 5Detection of GLUT2 translocation in Caco-2 cells in a fluorescence microscope. HR—aqueous extract from the fruit of Hipopphaë rhamnoides.
Data of mass spectrometry for compounds tentatively assigned in HR.
| No | Compound | Retention Time [min] |
| [M-H]-
| MS/MS |
|---|---|---|---|---|---|
| 1 | Isorhamnetin glycoside* | 22.0 | 280, 330 | 931 | 913, 813, 769, 423, 315 |
| 2 | Quercetin glycoside* | 25.6 | 270, 360 | 771 | 625, 446, 301 |
| 3 | Kaempferol glycoside* | 27.6 | 265, 344 | 755 | 623, 609, 285 |
| 4 | Isorhamnetin glycoside* | 28.9 | 265, 354 | 785 | 639, 607, 459, 315 |
| 5 | Isorhamnetin glycoside* | 34.5 | 265, 355 | 769 | 737, 605, 503, 423, 315 |
| 6 | Kaempferol glycoside* | 35.3 | 270 | 593 | 447, 431, 285 |
| 7 |
| 36.1 | 250, 270, 354 | 623 | 477, 315 |
| 8 | Isorhamnetin glycoside* | 36.5 | 270, 338 | 769 | 623, 461, 315 |
| 9 | Isorhamnetin feruloyl-glycoside* | 37.4 | 255, 351 | 961 | 816, 639, 315 |
| 10 |
| 41.5 | 254, 354 | 623 | 623, 477, 315 |
| 11 |
| 42.7 | 255, 354 | 477 | 314, 285 |
| 12 | Isorhamnetin derivative | 43.4 | 265, 354 | 593 | 477, 315 |
| 13 | Isorhamnetin malyl-glycoside* | 43.8 | 254, 354 | 739 | 623, 315 |
| 14 | Isorhamnetin derivative | 47.9 | 270, 344 | 637 | 965, 623, 482, 341, 315 |
| 15 | Isorhamnetin derivative | 56.5 | 270, 369 | 461 | 446, 315 |
| 16 | Kaempferol glycoside* | 57.4 | 270, 350 | 593 | 447, 285 |
Glc, glucosyl/glucoside; Rha, rhamnosyl/rhamnoside; in bold—isolated compounds; * assigned based on the available literature (Fang et al., 2013).
FIGURE 6HPLC chromatogram of HR (10 mg/ml) registered at 325 nm. The number codes were provided in Table 1.